Associated Papers
Recent advances in studies of SLCO2A1 as a key regulator of the delivery of prostaglandins to their sites of action.
Nakanishi T et al.
Pharmacology & Therapeutics, 2021
Novel SLCO2A1 mutations cause gender-differentiated pachydermoperiostosis.
Yuan L et al.
Endocrine Connections, 2018
Select a paper to view details